JBS N.V
JBS
12.24
+0.22
+1.83%
JBS N.V
US · JBS
#584 by market cap
Listed 1970
12.24
+0.22
+1.83%
Live - 5344 symbols - heartbeat 108s ago
· 2026-10-08 05:58
Pre-market
12.24
0.00%
After-hours
11.95
-2.35%
- Market cap
- 40.27B
- P/E (TTM)i
- 11.44
- P/Bi
- 4.90
- EPSi
- 1.89
- Div yieldi
- 8.17%
- 52W posi
- 24%
Reader sentiment
Are you bullish or bearish on JBS?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.15, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +11.66% YoY
Margins
- Gross margin
- 13.11%
- Operating margin
- 4.99%
- Net margin
- 2.35%
Key ratios & quality
- Enterprise valuei
- 57.15B
- Altman Z-Scorei
- 3.15
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 46.88B | 50.82B | 51.97B | 65.04B | 72.61B | 72.92B | 77.18B | 86.18B |
| Gross profit | 6.80B | 7.94B | 8.70B | 12.29B | 11.54B | 7.97B | 11.59B | 11.30B |
| Selling & admin expenses | 3.97B | 4.35B | 4.41B | 5.34B | 6.61B | 6.52B | 6.58B | 6.74B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 1.80B | 3.34B | 4.18B | 6.74B | 4.73B | 1.22B | 4.75B | 4.30B |
| Pretax profit | -283.42M | 1.86B | 1.59B | 5.06B | 3.55B | -259.73M | 2.71B | 2.62B |
| Tax | -337.64M | 256.66M | 694.22M | 1.24B | 409.96M | -127.99M | 743.39M | 390.51M |
| Net profit | 54.22M | 1.61B | 895.35M | 3.82B | 3.14B | -131.74M | 1.97B | 2.23B |
| Basic EPS | 0 | 1 | 0 | 2 | 1 | 0 | 2 | 2 |
| Diluted EPS | 0.00 | 0.57 | 0.33 | 1.54 | 1.34 | -0.19 | 1.65 | 1.89 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 19.53B | 21.00B | 22.60B | 23.06B | 21.61B | 23.90B |
| Gross profit | 2.62B | 2.83B | 2.97B | 2.87B | 2.32B | 2.59B |
| Selling & admin expenses | 1.59B | 1.59B | 1.69B | 1.85B | 1.76B | 1.79B |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 972.28M | 1.18B | 1.22B | 950.62M | 496.79M | 724.17M |
| Pretax profit | 694.10M | 736.50M | 815.34M | 374.36M | 308.69M | -222.08M |
| Tax | 137.77M | 142.18M | 171.22M | -60.66M | 67.10M | -125.91M |
| Net profit | 556.33M | 594.31M | 644.12M | 435.02M | 241.59M | -96.18M |
| Basic EPS | 0 | 0 | 1 | 0 | 0 | 0 |
| Diluted EPS | 0.47 | 0.48 | 0.52 | 0.39 | 0.20 | -0.10 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 9.52B | 10.42B | 11.64B | 15.06B | 15.22B | 16.24B | 17.12B | 18.44B |
| Cash & ST investments | 2.31B | 2.49B | 3.79B | 4.17B | 2.53B | 4.57B | 5.61B | 4.57B |
| Inventory | 3.74B | 4.31B | 4.37B | 6.09B | 7.25B | 6.81B | 6.62B | 7.93B |
| Total assets | 29.45B | 31.39B | 31.51B | 37.19B | 39.89B | 42.58B | 40.69B | 45.16B |
| Total current liabilities | 5.57B | 7.07B | 7.85B | 10.73B | 10.57B | 9.90B | 11.66B | 11.54B |
| Short-term debt | 261.27M | 673.53M | 843.18M | 2.43B | 1.10B | 1.13B | 1.30B | 1.19B |
| Long-term debt | 11.47B | 12.09B | 11.37B | 14.46B | 15.69B | 18.93B | 17.24B | 20.26B |
| Total liabilities | 22,242,939,899.93 | 23,321,490,371.47 | 23,130,913,060.20 | 28,610,881,360.80 | 30,339,365,000.00 | 32,870,048,000.00 | 32,551,009,000.00 | 35,633,695,000.00 |
| Total equity | 7.21B | 8.07B | 8.38B | 8.58B | 9.55B | 9.71B | 8.13B | 9.52B |
| Retained earnings | -- | -- | -- | -- | -- | -- | 0 | 2.09B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 17.32B | 15.89B | 17.67B | 18.44B | 17.62B | 17.76B |
| Cash & ST investments | 4.81B | 2.51B | 3.56B | 4.57B | 3.29B | 3.47B |
| Inventory | 7.42B | 8.09B | 8.39B | 7.93B | 8.64B | 8.81B |
| Total assets | 41.57B | 41.63B | 44.19B | 45.16B | 45.18B | 45.84B |
| Total current liabilities | 10.67B | 10.30B | 11.03B | 11.54B | 11.72B | 11.58B |
| Short-term debt | 1.14B | 1.38B | 1.11B | 1.19B | 1.21B | 1.70B |
| Long-term debt | 19.07B | 18.38B | 19.77B | 20.26B | 20.52B | 21.32B |
| Total liabilities | 33,339,892,381.66 | 32,425,710,767.32 | 34,676,954,000.00 | 35,633,695,000.00 | 36,119,603,000.00 | 36,779,315,000.00 |
| Total equity | 8.23B | 9.21B | 9.51B | 9.52B | 9.06B | 9.06B |
| Retained earnings | 507.86M | 1.11B | 1.67B | 2.09B | 220.59M | 118.49M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1.92B | 3.42B | 4.57B | 4.00B | 2.58B | 2.38B | 4.23B | 2.93B |
| Depreciation & amortization | 1.24B | 1.57B | 1.51B | 1.67B | 1.91B | 2.15B | 2.19B | 2.31B |
| Free cash flow | 1.17B | 2.36B | 3.41B | 2.21B | 399.56M | 867.65M | 2.74B | 825.56M |
| Dividends paid | -32.74M | -1.49M | -277.20M | -1.38B | -872.80M | -447.98M | -759.30M | -1.57B |
| Stock buybacks / issuance | -128.79M | -2.82M | -349.99M | -1.92B | -741.63M | 0 | -7.61M | -600.00M |
| Ending cash balance | 2.31B | 2.49B | 3.79B | 4.16B | 2.53B | 4.57B | 5.61B | 4.57B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -554.53M | 511.38M | 1.04B | 1.94B | -789.30M | 852.06M |
| Depreciation & amortization | 535.64M | 565.19M | 584.02M | 623.66M | 617.49M | 272.89M |
| Free cash flow | -821.86M | 62.03M | 490.46M | 1.09B | -1.36B | 237.38M |
| Dividends paid | -379.51M | -1.19B | 0 | 0 | 0 | -1.04B |
| Stock buybacks / issuance | 0 | 0 | -362.46M | -237.54M | 1.23M | 0 |
| Ending cash balance | 4.83B | 2.52B | 3.56B | 4.57B | 3.29B | 3.47B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 0.09 | 21.57 | 11.73 | 47.03 | 34.17 | -2.14 | 24.92 | 25.63 |
| ROA %i | 0.02 | 4.96 | 2.81 | 10.71 | 7.45 | -0.47 | 4.77 | 4.72 |
| ROIC %i | 3.38 | 12.61 | 6.74 | 19.69 | 14.51 | 2.41 | 10.32 | 10.57 |
| 5-year avg ROE %i | 5.34 | 8.72 | 7.34 | 17.59 | 24.09 | 23.10 | 23.17 | 25.95 |
| EBIT margin %i | 1.56 | 5.88 | 4.82 | 9.25 | 6.73 | 2.02 | 5.65 | 4.99 |
| FCF / sales %i | 2.49 | 4.64 | 6.57 | 3.37 | 0.55 | 1.19 | 3.55 | 0.96 |
| Current ratioi | 1.71 | 1.47 | 1.48 | 1.40 | 1.44 | 1.64 | 1.47 | 1.60 |
| Quick ratioi | 1.00 | 0.83 | 0.89 | 0.77 | 0.70 | 0.90 | 0.86 | 0.85 |
| Debt / assetsi | 39.82 | 43.63 | 41.70 | 48.70 | 45.55 | 50.62 | 49.02 | 50.62 |
| LT debt / equityi | 173.28 | 176.85 | 159.32 | 198.06 | 191.82 | 226.28 | 262.75 | 248.98 |
| Interest coveragei | 0.72 | 2.65 | 2.73 | 6.16 | 3.64 | 0.85 | 2.65 | 2.56 |
| Revenue CAGR (3Y) %i | 4.46 | -0.97 | 1.82 | 11.53 | 12.63 | 11.95 | 5.87 | 5.88 |
| Net income CAGR (3Y) %i | -82.29 | 175.99 | 76.38 | 736.90 | 25.74 | -- | -22.61 | -12.26 |
| FCF CAGR (3Y) %i | 40.08 | -- | 76.10 | 23.71 | -44.65 | -36.65 | 7.44 | 27.37 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 23.84 | 26.64 | 23.36 | 25.63 | 22.15 | 13.42 |
| ROA %i | 4.73 | 5.48 | 4.71 | 4.72 | 4.02 | 2.55 |
| ROIC %i | 9.31 | 10.65 | 9.73 | 10.57 | 9.77 | 8.33 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 5.94 | 5.94 | 5.44 | 4.99 | 4.50 | 3.47 |
| FCF / sales %i | 3.05 | 1.52 | 0.89 | 0.96 | 0.32 | 0.51 |
| Current ratioi | 1.62 | 1.54 | 1.60 | 1.60 | 1.50 | 1.53 |
| Quick ratioi | 0.84 | 0.66 | 0.73 | 0.85 | 0.70 | 0.70 |
| Debt / assetsi | 51.96 | 50.85 | 50.53 | 50.62 | 51.23 | 53.33 |
| LT debt / equityi | 272.19 | 236.08 | 243.32 | 248.98 | 266.52 | 276.51 |
| Interest coveragei | 2.85 | 2.99 | 2.71 | 2.56 | 2.29 | 1.68 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Diversified
- Beef North America is the largest reported line at 32.51% of revenue, across 8 reported segments.
- No single line clears half of revenue; Pilgrim’s Pride is next at 19.34%, spreading the business across more than one real driver.
Revenue breakdown most recent period
Business
Beef North America32.51%
Pilgrim’s Pride19.34%
Brazil19.18%
Australia10.73%
Seara10.71%
Pork United States of America (USA)8.70%
Others1.54%
Quote time 2026-10-08 05:58:47 · For reference only, not investment advice and not tailored to your situation.